Snowdome Foundation is pleased to announce that Expressions of Interest (EOIs) are now open for the 2026 Snowdome Foundation Research Impact Program.

The Snowdome Foundation Research Impact Program aims to support high quality research and clinical trials that will accelerate the translation of treatments into improved outcomes for Australians affected by blood cancer.

With funding up to $450,000 AUD (plus GST) available, the program supports high-quality blood cancer research and clinical trials that have the potential to accelerate translation into improved outcomes for patients.

Projects should demonstrate a clear pathway to impact within 3-5 years and align with one or more of Snowdome’s strategic priorities, including translational research, clinical trials, genomics, precision medicine, targeted therapies and cellular therapies.

Expression of Interest (EOI) close 23 November 2026 (midnight).
Outcomes announced February 2027.

For more information, click here.
To download EOI application form, click here.